Please wait

1

Exhibit 10.1

SEPARATION AGREEMENT & GENERAL RELEASE OF ALL CLAIMS

This General Release of all Claims (this “Agreement”) is entered into by Karsten

Voermann (the “Executive”) and GoodRx, Inc., a Delaware corporation (the “Corporation”),

effective as of the Effective Date as defined herein. In consideration of the promises set forth

herein, the Executive and the Corporation agree as follows:

1.Termination and Return of Property. The Executive’s employment with the

Corporation in any capacity has terminated effective January 17, 2025 (“Separation Date”). All

files, access keys and codes, desk keys, ID badges, computers, records, manuals, electronic

devices, computer programs, papers, electronically stored information or documents, telephones

and credit cards, and any other property of the Corporation or any affiliate thereof previously in

the Executive’s possession or control has been returned to the Corporation or will be returned on

or before the Separation Date.

2.Separation Benefits. As consideration for Executive’s execution, performance,

and non-revocation of this Agreement, and contingent upon Executive’s continued compliance

with Section 3 below and the provisions of his executed Proprietary Information and Invention

Assignment Agreement (“PIIA”), the Corporation shall provide Executive with the following:

(a)Incentive Bonus: Subject to approval by the Board of Directors, the Executive

will remain eligible for payment of an Incentive Bonus targeted at one hundred

percent (100%) of Executive’s annual Base Salary pursuant to Paragraph 3.2 of

his March 4, 2024, Employment Agreement (“Employment Agreement”), except

that such Paragraph 3.2 is amended to strike the phrase “subject to the Executive’s

continued employment by the Corporation or its affiliates through the payment

date.” For the avoidance of doubt, this means that the Executive will remain

eligible after the Separation Date for payment of an Incentive Bonus for 2024 in

an amount determined by the Board of Directors based upon achievement of

applicable Company performance goals, which shall be paid as soon as practicable

following the Board’s approval of the amount of the Incentive Bonus, but in any

case, no later than March 15, 2025.

(b)Option Exercise Extension: Subject to approval by the Board of Directors,

Executive will be granted an extension of up to twelve (12) months after the

Separation Date to exercise any vested, unexercised option shares granted under

any GoodRx Holdings, Inc. Equity Incentive Plan, regardless of any language in

the Plans or option agreement(s) that may specify a shorter exercise period. To the

extent that Executive does not exercise such options by the end of this 12-month

period, all remaining vested but unexercised option shares will be canceled, and

all option agreements will terminate. As of the Separation Date, any unvested

RSUs granted to the Executive under any GoodRx Holdings, Inc. stock plans will

be canceled, and Executive will have no further rights with respect to those

unvested RSUs.

Other than as set forth in this Paragraph 2, Executive acknowledges that he has no

other rights, title or interest in any other options or shares of capital stock of the

2

Company or GoodRx Holdings, Inc. or other securities therein and no other rights

to purchase any such securities. Further, except as set forth herein, Executive shall

have no further rights to any compensation or any other benefits under the

Employment Agreement, or any other agreements, from and after the Separation

Date. Executive agrees that he is not entitled to Salary Severance or other separation

benefits contemplated in and under the conditions set forth in his Employment

Agreement given the voluntary nature of his separation of employment; however,

for the avoidance of doubt, Executive expressly waives any right to such Salary

Severance or other separation benefits as set forth in the Employment Agreement.

3.General Release and Waiver of Claims.

(a)Release By Executive. Having consulted with counsel, the Executive, on

behalf of himself and each of his respective heirs, executors, administrators, representatives,

agents, insurers, successors and assigns (collectively, and including the Executive, the

“Releasors”) hereby irrevocably and unconditionally releases and forever discharges the

Corporation, its parents (including GoodRx Holdings, Inc. (“Holdings”)), subsidiaries and

affiliates and each of their respective officers, employees, directors, members, shareholders,

parents, subsidiaries and agents (collectively, the “Releasees”) from any and all claims, actions,

causes of action, rights, judgments, obligations, damages, demands, accountings or liabilities of

whatever kind or character (collectively, “Claims”), which the Executive now has or may

hereafter have against the Releasees, or any of them, by reason of any matter, cause, or thing

whatsoever from the beginning of time to the date hereof (including, without limitation, any

Claims under any federal, state, local or foreign law that they may have, or in the future may

possess, arising out of the Executive’s employment relationship with and service as an

employee, officer or director of the Corporation, its parent entity (including Holdings) or any

other subsidiaries of such parent entity, and the termination of such relationship or service);

provided, however, that the Executive does not release, discharge or waive any rights to (i)

payments and benefits provided under this Agreement or under any other agreement between

Executive and any of the Releasees that would, by their nature, survive the termination of

employment, (ii) equity and other securities of Holdings or rights under agreements with any of

the Releasees related to the Executive’s equity securities of Holdings (unless modified by this

agreement), (iii) benefit claims under any employee benefit plans in which Executive is a

participant by virtue of his employment with the Corporation arising after the execution of this

Agreement by Executive, (iv) any indemnification, advance or reimbursement rights the

Executive may have in accordance with applicable law, indemnification agreements, certificate

of incorporation or bylaws of Corporation, or under any director and officer liability insurance

or other insurance maintained by the Corporation or a parent entity with respect to liabilities

arising as a result of the Executive’s service as an officer and employee of such entities, and (v)

claims that cannot be waived by an employee under applicable law. This Paragraph 3(a) does

not apply to any Claims that the Executive may have as of the date the Executive signs this

Agreement arising under the Federal Age Discrimination in Employment Act of 1967, as

amended, and the applicable rules and regulations promulgated thereunder (“ADEA”) or any

other claims that may not be released as a matter of law. Claims arising under ADEA are

addressed in Paragraph 3(c) of this Agreement.

3

(b)Unknown Claims. The Executive acknowledges that he may hereafter

discover Claims or facts in addition to or different from those which the Executive now knows or

believes to exist with respect to the subject matter of this release and which, if known or

suspected at the time of executing this release, may have materially affected this release or the

Executive’s decision to enter into it. Nevertheless, the Executive hereby waives any right or

Claim that might arise as a result of such different or additional Claims or facts. In addition, the

Executive, on behalf of himself and the other Releasors, hereby waives any and all rights and

benefits conferred upon him and the other Releasors by the provisions of Section 1542 of the

Civil Code of the State of California, which provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS

THAT THE CREDITOR OR RELEASING PARTY DOES NOT

KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT

THE TIME OF EXECUTING THE RELEASE AND THAT, IF

KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY

AFFECTED HIS OR HER SETTLEMENT WITH THE

DEBTOR OR RELEASED PARTY.

(c)Specific Release of ADEA Claims. In further consideration of the

payments and benefits provided to the Executive under this Agreement, the Executive, on behalf

of himself and the other Releasors, hereby unconditionally releases and forever discharges the

Releasees from any and all Claims arising under ADEA that the Releasors may have as of the

date the Executive signs this Agreement. By signing this Agreement, the Executive hereby

acknowledges and confirms the following:

i.the Executive was advised by the Corporation in connection with his

termination to consult with an attorney of his choice prior to signing this

Agreement and to have such attorney explain to the Executive the terms of

this Agreement, including, without limitation, the terms relating to the

Executive’s release of claims arising under ADEA;

ii.the Executive was given a period of not fewer than twenty-one (21) days to

consider the terms of this Agreement and to consult with an attorney of his/

her choosing with respect thereto;

iii.having read the terms of this Agreement, the Executive understands its terms

and effects, and the Executive knowingly and voluntarily accepts the terms

of this Agreement; and

iv.the Executive is providing this release and discharge only in exchange for

consideration in addition to anything of value to which the Executive is

already entitled, and acknowledges such consideration is adequate and

satisfactory to the Executive.

The Executive also understands that he has seven (7) days following the date on which

he signs this Agreement within which to revoke the release contained in this paragraph, by

providing the Corporation with a written notice of his revocation of the release and waiver

contained in this paragraph. Any revocation must be in writing to Gracye Cheng, General

Counsel & SVP, via electronic mail at gracye@goodrx.com, on or before 5:00 p.m. Pacific

Time on the seventh day after this Agreement is executed by the Executive. If this Agreement

4

is not revoked during this seven (7) day period, this Agreement shall be effective on the 8th

day following the date of Executive’s execution of this Agreement (the “Effective Date”).

(d)No Assignment. The Executive represents and warrants that he has not

assigned or otherwise transferred any of the Claims being released under this Agreement. The

Corporation may assign this Agreement, in whole or in part, to any affiliated entity, including

subsidiaries of the Corporation, or any successor in interest to the Corporation.

4.            Proceedings.

(a)General Agreement Relating to Proceedings. The Executive has not

filed, and except as provided in Paragraphs 4(b) and 4(c), the Executive agrees not to initiate

or cause to be initiated on his behalf, any complaint, charge, claim or proceeding that is

released hereunder against any party released herein before any local, state or federal agency,

court or other body, other than with respect to the obligations of the Corporation or any other

party released herein to the Executive under this Agreement or any indemnification or other

rights the Executive may have as listed in Paragraph 3(a) (each, individually, a “Proceeding”),

and agrees not to participate voluntarily in any Proceeding. The Executive waives any right he

may have to benefit in any manner from any relief (whether monetary or otherwise) arising

out of any Proceeding.

(b)Proceedings Under ADEA. Paragraph 4(a) shall not preclude the

Executive from filing any complaint, charge, claim or proceeding challenging the validity of

the Executive waiver of Claims arising under ADEA (which is set forth in Paragraph 3(c) of

this Agreement). However, both the Executive and the Corporation confirm their belief that

the Executive’s waiver of claims under ADEA is valid and enforceable, and that their intention

is that all claims under ADEA will be waived.

(c)Certain Administrative Proceedings. In addition, Paragraph 4(a) shall

not preclude the Executive from filing a charge with, or participating in any administrative

investigation or proceeding by, the Equal Employment Opportunity Commission, the SEC,

FINRA, or any other Government Agencies or fair employment agency, without notice to the

Company; (2) exercising any protected rights, to the extent such rights cannot be waived by

agreement; (3) discussing or disclosing information about unlawful acts in the workplace, such

as harassment, discrimination or any other conduct or employment practice that Executive has

reason to believe is unlawful or another fair employment practices agency. The Executive is,

however, waiving his right to recover money in connection with any such charge or

investigation to the extent released hereunder. The Executive is also waiving his right to recover

money in connection with a charge filed by any other entity or individual, or by any federal,

state or local agency to the extent released hereunder.

5.Exceptions. Notwithstanding anything in this Agreement to the contrary,

nothing contained in this Agreement shall prohibit the Executive from (i) filing a charge with,

reporting possible violations of federal law or regulation to, participating in any investigation

by, or cooperating with any governmental agency or entity or making other disclosures that are

protected under the whistleblower provisions of applicable law or regulation and/or (ii)

communicating directly with, cooperating with, or providing information (including trade

secrets) in confidence to, any federal, state or local government regulator (including, but not

5

limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading

Commission, or the U.S. Department of Justice) for the purpose of reporting or investigating a

suspected violation of law, or from providing such information to the Executive’s attorney or

in a sealed complaint or other document filed in a lawsuit or other governmental proceeding.

Pursuant to 18 USC Section 1833(b), the Executive will not be held criminally or civilly liable

under any federal or state trade secret law for the disclosure of a trade secret that is made: (x)

in confidence to a federal, state, or local government official, either directly or indirectly, or to

an attorney, and solely for the purpose of reporting or investigating a suspected violation of law;

or (y) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is

made under seal. Nothing in this Agreement prevents the Executive from discussing or

disclosing information about unlawful acts in the workplace, such as harassment or

discrimination or any other conduct that the Executive has reason to believe is unlawful.

6.Cooperation. The Executive and Corporation agree that certain matters in

which the Executive has been involved during the Executive’s employment, including any

litigation or disputes involving the Corporation related to matters in which the Executive has

been involved, may need the Executive’s cooperation with the Corporation in the future.

Accordingly, for a period of 12 months after the Separation Date, to the extent reasonably

requested by the Corporation, the Executive shall cooperate with the Corporation and appear

as a witness, if necessary, regarding matters arising out of or related to the Executive’s service

to the Corporation, provided that the Corporation shall make reasonable efforts to minimize

disruption of the Executive’s other activities. The Corporation shall reimburse the Executive

for reasonable expenses incurred in connection with this cooperation.

7.Severability Clause. In the event that any provision or part of this Agreement

is found to be invalid or unenforceable, only that particular provision or part so found, and not

the entire Agreement, shall be inoperative.

8.Non-Admission. Nothing contained in this Agreement shall be deemed or

construed as an admission of wrongdoing or liability on the part of the Corporation or Executive.

9.Governing Law and Forum. This Agreement and all matters or issues

arising out of or relating to this Agreement shall be governed by the laws of the State of

California applicable to contracts entered into and performed entirely therein. Any action to

enforce this Agreement shall be brought solely Los Angeles, California.

10.Arbitration. Any dispute or controversy arising under or in connection with

this Agreement or otherwise in connection with the Executive’s employment by the

Corporation that cannot be mutually resolved by the parties to this Agreement and their

respective advisors and representatives shall be settled exclusively by arbitration in accordance

with the provisions of Section 16 of the Employment Agreement.

11.Notices. Notices under this Agreement must be given as is specified in Section

17 of the Employment Agreement.

THE EXECUTIVE ACKNOWLEDGES THAT HE HAS READ

THIS AGREEMENT AND THAT HE FULLY KNOWS,

UNDERSTANDS AND APPRECIATES ITS CONTENTS, AND

6

THAT HE HEREBY EXECUTES THE SAME AND MAKES THIS

AGREEMENT AND THE RELEASE AND AGREEMENTS

PROVIDED FOR HEREIN VOLUNTARILY AND OF HIS OWN

FREE WILL.

This Agreement is acceptable to you, the Executive, please sign below no later than

5:00 pm Pacific Time on February 7, 2025. If the Agreement is not signed by this date and

time, it will be automatically withdrawn and invalid.

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the dates

set forth below.

“CORPORATION”

By:	/s/ Gracye Cheng
	Gracye Cheng
Its:	General Counsel & SVP
Dated:	1/17/2025

“EXECUTIVE”

/s/ Karsten Voermann
Karsten Voermann
Dated:	1/17/2025